Go to the list of all blogs
AI dvisor's Avatar
published in Blogs
Nov 04, 2026
TickeronGET DAILY SIGNALS
BRX, CUZ, and STAG: Weighing Three REITs in Retail, Office, and Industrial Real Estate

BRX, CUZ, and STAG: Weighing Three REITs in Retail, Office, and Industrial Real Estate

Key Takeaways

  • All three names are real estate investment trusts (REITs), but they operate in different sectors: BRX in grocery-anchored retail, CUZ in Sun Belt office, and STAG in single-tenant industrial properties.
  • BRX recently reported record occupancy, a dividend increase of more than 7%, raised guidance, and a large pending acquisition, giving it the broadest set of positive catalysts.
  • CUZ delivered the strongest funds-from-operations (FFO) growth of the group, but its office exposure carries the highest sector-specific risk profile.
  • STAG offers steady industrial fundamentals and newly confirmed investment-grade ratings, positioning it as the most defensive of the three.
  • Tickeron AI Verdict: Based on trend consistency, operational momentum, and catalyst depth, the AI favors BRX as the most compelling of the three.

Setting the Stage for the Comparison

This analysis looks at three publicly traded REITs that compete for investor attention in different segments of U.S. commercial real estate. Brixmor Property Group focuses on grocery-anchored shopping centers, Cousins Properties targets Class A office buildings in high-growth Sun Belt markets, and STAG Industrial holds single-tenant warehouse and distribution assets. Each follows the REIT structure, yet their models, growth drivers, and risk exposures vary in ways that matter for income-oriented investors assessing dividend reliability and for those tracking recent momentum across the sector. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

BRX Overview and Recent Performance

BRX (Brixmor Property Group) owns and operates a national portfolio of grocery-anchored community and neighborhood shopping centers. In the most recent quarter, the company posted record total leased occupancy of 95.6% and same-property net operating income growth of 6.6%, among the stronger results in its peer set. Management lifted full-year FFO guidance and raised the quarterly dividend by 7.3%, signaling solid cash-flow visibility. A key catalyst is the announced acquisition of Slate Grocery REIT in a deal valued at roughly $2.34 billion, which would enlarge its grocery-anchored presence. Leasing spreads above 25% on comparable space highlight the mark-to-market potential in the portfolio. From what I see, analyst sentiment has stayed constructive, with several firms lifting price targets recently.

CUZ Overview and Recent Performance

CUZ (Cousins Properties) develops, acquires, and manages Class A office towers concentrated in fast-growing Sun Belt cities including Atlanta, Austin, Charlotte, Tampa, Phoenix, Dallas, and Nashville. In the latest quarter, FFO per share rose about 8% year over year to $0.75, office leased occupancy reached 93.0%, and same-property cash NOI increased 7.4%. Management raised full-year FFO guidance and has been recycling capital by selling non-core assets while acquiring and developing in preferred submarkets. A notable win came with an Oracle lease at its Nashville development. Even so, the office sector faces ongoing structural challenges, and leverage plus financing costs remain areas to watch. Recent leasing trends in the Sun Belt have taken on a more positive tone.

STAG Overview and Recent Performance

STAG (STAG Industrial) acquires, owns, and operates single-tenant warehouse and distribution buildings across the United States. The most recent quarter showed total revenue of $231 million and Core FFO of $0.66 per share, with portfolio occupancy at 95.9%. Same-store cash NOI grew 3.5%, and leasing spreads reached 23.8% on a cash basis. Data-center-related leasing has accounted for about 26% of new leasing since 2025. STAG received an inaugural investment-grade rating from S&P Global Ratings, adding to existing ratings from Fitch and Moody’s, and announced a new $250 million share repurchase program. While industrial fundamentals have been constructive, management has signaled caution on near-term acquisition activity amid capital-market conditions.

Head-to-Head Comparison

The clearest differences among the three REITs appear in sector exposure and growth characteristics. BRX benefits from limited new retail supply and strong rent mark-to-market, delivering the highest same-property NOI growth of the group, though its results hinge on consumer resilience. CUZ posted the highest FFO growth rate and attractive rent gains, yet its office focus makes it most sensitive to occupancy changes and refinancing conditions. STAG provides the steadiest, most diversified income stream with strong credit quality, though its more modest same-store growth and lower rent escalation limit upside momentum relative to peers. All three are sensitive to interest-rate expectations, but CUZ carries higher financial leverage than the other two. On recent sentiment, BRX and CUZ have seen more favorable analyst revisions, while STAG maintains a steadier, defensive stance. One thing that stands out is how these profiles align with different investor priorities.

Tickeron AI Verdict

Based on observable factors rather than forecasts, Tickeron’s AI would likely favor BRX among the three. The stock combines the strongest same-property operating momentum, record occupancy, a dividend increase, and raised guidance with a sizable, potentially accretive acquisition catalyst that extends its growth runway. Its trend has been more consistent than the office-linked volatility of CUZ and more dynamic than the steadier but slower-growing STAG. While no outcome is certain and each name offers distinct merits, the balance of trend consistency, catalyst depth, and relative positioning currently appears most favorable for BRX. I’m watching this closely as the acquisition closes.

Using Tickeron’s AI Trading Bots in Practice

In my own process, I often review Tickeron’s AI Trading Bots to test how systematic strategies perform across REIT names like these. The platform provides a range of automated approaches with different timeframes and risk settings, allowing me to benchmark signals against the fundamental picture. This has helped me gauge momentum consistency without replacing core analysis.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CUZ, STAG, BRX

CUZ in upward trend: 10-day moving average broke above 50-day moving average on October 28, 2026

The 10-day moving average for CUZ crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 65%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on CUZ as a result. In 61 of 101 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 60%.

The Moving Average Convergence Divergence (MACD) for CUZ just turned positive on October 06, 2026. Looking at past instances where CUZ's MACD turned positive, the stock continued to rise in 30 of 47 cases over the following month. The odds of a continued upward trend are 64%.

CUZ moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +2.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where CUZ advanced for three days, in 182 of 312 cases, the price rose further within the following month. The odds of a continued upward trend are 58%.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CUZ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.

CUZ broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CUZ entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. CUZ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 56 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.030) is normal, around the industry mean (0.873). CUZ has a moderately high P/E Ratio (701.500) as compared to the industry average of (201.021). Projected Growth (PEG Ratio) (0.620) is also within normal values, averaging (0.666). Dividend Yield (0.046) settles around the average of (0.163) among similar stocks. P/S Ratio (4.384) is also within normal values, averaging (2.856).

The Tickeron SMR rating for this company is 90 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CUZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

Market Cap

The average market capitalization across the REIT - Office Industry is 2.43B. The market cap for tickers in the group ranges from 6.34M to 9.97B. BXP holds the highest valuation in this group at 9.97B. The lowest valued company is CMCT at 6.34M.

High and low price notable news

The average weekly price growth across all stocks in the REIT - Office Industry was 6%. For the same Industry, the average monthly price growth was 8%, and the average quarterly price growth was 291%. FSP experienced the highest price growth at 36%, while CMCT experienced the biggest fall at -12%.

Volume

The average weekly volume growth across all stocks in the REIT - Office Industry was 2%. For the same stocks of the Industry, the average monthly volume growth was 48% and the average quarterly volume growth was -32%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 38
P/E Growth Rating: 65
Price Growth Rating: 54
SMR Rating: 89
Profit Risk Rating: 92
Seasonality Score: 0 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a real estate investment trust

Industry REITOffice

Industry
Real Estate Investment Trusts
Address
3344 Peachtree Road NE
Phone
+1 404 407-1000
Employees
305
Web
https://www.cousins.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
RBLX shares plunged approximately 24% in premarket trading on Friday, May 1, 2026, falling roughly $13.36 to around $41.90 from the prior close of approximately $55.26. The primary catalyst was a dramatic cut to full-year 2026 bookings guidance, slashed to $7.33B–$7.60B from $8.28B–$8.55B.
SMMT shares fell approximately 20% in premarket trading on Friday, May 1, 2026, dropping from a prior close of approximately $20.83 to around $16.66. The primary catalyst was the HARMONi-3 interim PFS analysis miss, with the Phase III global trial failing to meet expectations for its squamous cohort, undermining the ivonescimab thesis.
BRX, CUZ, and STAG: Weighing Three REITs in Retail, Office, and Industrial Real Estate